NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in Sidoti’s Micro-Cap Virtual Conference taking place August 16-17, 2023. Management will be presenting a corporate overview on August 17 at 10:00am Eastern time and will be hosting one-on-one meetings with investors.
The presentation will be webcast live and available for replay in the Investors section of LifeMD’s website by clicking here. To register for the conference, visit www.sidoti.com/events. Registration is free and investors are not required to be a Sidoti client.
About LifeMD™
LifeMD is a direct-to-patient telehealth company with a portfolio of brands that offer virtual primary care, diagnostics, and specialized treatment for men’s and women’s health, allergy & asthma, and dermatological conditions. By leveraging its proprietary technology platform, 50-state affiliated medical group, and nationwide mail-order pharmacy network, LifeMD is increasing access to top-notch healthcare that is affordable to anyone. To learn more, go to LifeMD.com.
Media Contact
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact
Marc Benathen, CFO
This email address is being protected from spambots. You need JavaScript enabled to view it.

| Last Trade: | US$3.84 |
| Daily Volume: | 0 |
| Market Cap: | US$184.860M |
November 17, 2025 November 17, 2025 November 04, 2025 September 18, 2025 | |

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load